CClinicalTrials.gg
RecruitingNCT06517238ComDentODFPrevUpdated Jul 24, 2024

A New Digital Communication Tool Between Dentist and Orthodontist to Improve Dental Prevention

An observational study in Reduction in DMFT Index and Plaque Index in Patients at the Treatment Completion, an Average of 4 Years and DMFT Index, ICDAS Score, Dental Plaque Index, Communication, Prevention, Dentist, Orthodontist, sponsored by CHU de Reims. Recruiting at 1 site in France. Open to participants aged 8 Years to 18 Years. Per ClinicalTrials.gov, last updated 2024-07-24.

Sponsored by CHU de Reims · Observational

From the registry’s dates

  • Started Jan 2024; still recruiting 2 years 9 months later.
Study type
Observational
Model
Cohort
Time perspective
Retrospective
Enrollment
30
Ages
8 Years to 18 Years
Sex
All
01

Study summary

Dentists and orthodontists of the oral medicine department of Reims University Hospital noted that many children presented white spots around orthodontic brackets, or decays at the end of their multi-brackets orthodontic treatment. These defects required dental cares and sometimes led to dental avulsions. These situations highlighted a poor oral hygiene of children (poorly done or insufficient dental brushing), a lack of oral prevention of their dentist and/or orthodontist, or even a lack of communication between these two practitioners.

The objective of this study is to evaluate if a regular prevention and a specific communication between dentist and orthodontists could reduce the individual caries-risk of patients with multi-brackets orthodontic treatment. During all the orthodontic treatment, a semi-annual oral prevention consultation will be established for each patient, and a digital communication tool will be made available to dentists and orthodontists to facilitate their exchanges.

The study population consists of children under 18 years-old when laying multi-brackets orthodontic treatment.

The study population consists of children aged 8 to 18 years-old (at the start of treatment) treated with multi-brackets orthodontic treatment. The study population is divided in two groups: (i) a control group corresponding to children not benefiting from regular oral preventive follow up monitoring and completing their orthodontic treatment during the year in 2024; (ii) a study group composed of children starting their orthodontic treatment during the year in 2024 and benefiting from regular oral prevention every 6 months, up to four years.

Several parameters will be evaluated from patient medical records: the caries index, the ICDAS score, the plaque index, the oral hygiene and food habits. Concerning the study group, a new digital communication tool will be made available to the dentist and the orthodontist to monitor the oral hygiene of patients. An evaluation of the oral hygiene will be done every 6 months.

The expected outcomes of this study concern the interest of (i) a bi-annual prevention consultation to reduce caries risk, (ii) a regular communication between practitioners to adjust the orthodontic treatment according to the individual caries-risk.

The expected hypothesis is to decrease the patient's caries and plaque indexes in the study group.

Read the detailed description

The study population consists of children under 18 years-old when laying multi-brackets orthodontic treatment in the oral medicine department of Reims University Hospital. This population is distributed into 2 groups. The control group consists in children having completed their orthodontic treatment by December 2024, (n=30). The study group consists in children starting their orthodontic treatment during 2024 and benefiting from semi-annual oral prevention during four years-treatment. Moreover, their dentists and orthodontists will be able to access a digital communication tool to facilitate their exchanges. The number of patients in the study group will depend on the number of the patients in the control group.

The study protocol was approved by a regulatory agreement of the RGPD (register of processing activities) of Reims University Hospital since 14/11/23. All data will be anonymized. These data correspond to those that are systematically and usually collected by professionals during the orthodontic treatment. They will be stored in a secure computer located in the oral medicine department. The aim of the study and clinical procedures will be explained to the parents and the children to obtain their informed consent.

Data collected for control group at the treatment completion, an average of 4 years: put out the treatment:

  • Sex: Girl/Boy/Non-Registered
  • Date of birth (month/year) / age
  • Processing end date
  • Regular orthodontic appointment
  • Socio-Professional Category (PCS 2020 level 1 nomenclature: 6 levels INSEE) : farmers; artisans, traders and business leaders; executives and higher intellectual professions; intermediate professions ; employees ; workers
  • Decayed, missing and filled teeth index (DMFT Index)
  • ICDAS score (International Caries Detection and Assessment System)
  • Decays under dental restauration
  • Modified orthodontic plaque index (MOP Index)
  • Individual carious risk (based on HAS-France):

    • Regular brushing
    • Manual or electric brushing
    • Presence of snacking and soda
    • Taking long-term sweet or medication causing hyposialia
    • Presence of dental plaque visualized by dental plaque disclosing tablet
    • Presence of dental plaque visible without dental plaque disclosing tablet
    • Presence of enamel demineralization
    • Presence of caries lesions (dentin involvement) and/or reversible initial lesions (enamel involvement)
    • Serrated grooves in molars
    • Grooves treated by Sealent
    • Fluoride varnish
  • Presence of gingival hyperplasia

Data collected for study group during each consultation before the orthodontic treatment and followed every 6 months, up to 4 years:

  • Appointment date
  • Sex: Girl/Boy/Non-Registered
  • Date of birth (month/year) / age
  • Regular follow-up with a dentist
  • Socio-Professional Category (PCS 2020 level 1 nomenclature: 6 levels INSEE) : farmers; artisans, traders and business leaders; executives and higher intellectual professions; intermediate professions ; employees ; workers
  • Decayed, missing and filled teeth index (DMFT Index)
  • ICDAS score (International Caries Detection and Assessment System)
  • Plaque Index Silness et Loe before treatment
  • Modified orthodontic plaque index (MOP Index) as soon as the treatment is applied
  • Molar Incisor Hypomineralization (MIH): degree of severity (moderate - severe), type of teeth affected (molars - incisors), number of teeth treated
  • Amelar abnormality: incisal dysplasia, number of teeth treated
  • Individual carious risk (based on HAS-France):

    • Regular brushing
    • Manual or electric brushing
    • Presence of snacking and soda
    • Taking long-term sweet or medication causing hyposialia
    • Presence of dental plaque visualized by dental plaque disclosing tablet
    • Presence of dental plaque visible without dental plaque disclosing tablet
    • Presence of enamel demineralization
    • Presence of caries lesions (dentin involvement) and/or reversible initial lesions (enamel involvement)
    • Serrated grooves in molars
    • Grooves treated by Sealent
    • Fluoride varnish
  • Presence of gingival hyperplasia
  • Need for prevention and/or care sessions
02

Conditions studied

  • Reduction in DMFT Index and Plaque Index in Patients at the Treatment Completion, an Average of 4 Years
  • DMFT Index, ICDAS Score, Dental Plaque Index, Communication, Prevention, Dentist, Orthodontist

Browse trials for

Keywords

  • Carious lesions
  • individual caries-risk
  • plaque index
  • prevention
  • communication
  • dentist
  • orthodontist
  • ICDAS
03

In context

Dental Plaque

314 studies on the registry are indexed under Dental Plaque; 54 are open to participants now.

This study's planned enrollment of 30 is below the median of 60 across 33 observational studies indexed under Dental Plaque.

Browse Dental Plaque studies →

Lead sponsor

CHU de Reims is the lead sponsor of 267 studies on the registry; 50 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
8 Years to 18 Years
Sexes eligible
All
Sampling method
Non-probability sample

Study population

Patients were 8 and 18 years old

Inclusion criteria

Patients aged under 18 years old when laying treatment. They required multi-brackets orthodontic treatment in the oral medicine department of the Reims University Hospital

Exclusion criteria

Exclusion criteria:

  • children under 8 years old
  • Patients requiring other orthodontic treatment than multi-brackets,
  • Patients requiring any orthodontic treatment
  • disabled (with a loss of autonomy that don't allow proper brushing)
  • dental pathologies like amelogenesis imperfect, dentinogenesis imperfect, ectodermal dysplasia.
05

Study design

Observational model
Cohort
Time perspective
Retrospective
Enrollment
30 participants (estimated)
Patient registry
No

Groups and cohorts

  • Study group

    Children starting a multi-brackets orthodontic treatment in the oral medicine department of University Hospital of Reims from January 2024. These childrens benefit from semi-annual appointment to analyze their oral health and their individual caries-risk by dentist. Moreover, these results will be communicated with a digital tool to orthodontist who can choose to adapt the orthodontic treatment of these childrens.

    Other: There is no intervention

  • Control group

    Other: There is no intervention

Interventions

  • OtherThere is no intervention

    Observal Study.There is no intervention

06

What researchers measure

Primary outcomes

  1. Measure of DMFT index

    Number of Decayed, Missing due to caries, and Filled Teeth

    Time frame: every 6 months, up to 4 years

  2. Measure of plaque index (Silness and Loe)

    * Score 0 : absence of microbial plaque * Score 1 : film of bacterial plaque invisible to the naked eye; but thin film of microbial plaque along the free gingival margin collected with a probe * Score 2 : moderate accumulation with plaque in the sulcus visible to naked eye * Score 3 : large amount of plaque visible in sulcus or pocket along the free gingiva margin up to 2mm thick.

    Time frame: every 6 months, up to 4 years

  3. Modified Orthodontic Plaque index (MOP)

    * Score 0 : no plaque. * Score 1 : accumulation of mesial and/or distal plaque at the base of the attachment. * Score 2 : accumulation of mesial, distal, incisal and/or cervical plaque at the base of the attachment. * Score 3 : continuous plaque accumulation from the marginal gingiva to the base of the attachment. * Score 4 : complete coverage by the plaque.

    Time frame: every 6 months, up to 4 years

  4. Measure of ICDAS score

    * 0 No evidence of caries * 1 Initial caries * 2 Distinct visual change in enamel * 3 Localised enamel breakdown due to caries with no visible dentine * 4 Underlying dark shadow from dentine * 5 Distinct cavity with visible dentine * 6 Extensive distinct cavity with visible dentine

    Time frame: every 6 months, up to 4 years

  5. Socio-Professional Category

    * Farmers, * artisans, * traders and business leaders, * executives and higher intellectual professions, * intermediate professions, * employees, * workers

    Time frame: Day 1

Secondary outcomes

  1. Communication needed between dentist and orthodontist

    focus group of dentist and orthodontist at the beginning and at the end of the study

    Time frame: At 48 months

07

Study locations

1 of 1 sites recruiting
  • Damien JOLLY
    Reims, France
    Recruiting
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 24, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06517238
Lead sponsor
CHU de Reims
Responsible party
Sponsor
First posted
Jul 24, 2024
Start date
Jan 1, 2024
Primary completion
Dec 1, 2029 (estimated)
Completion
Dec 1, 2029 (estimated)
Last update
Jul 24, 2024

Study contacts

Charline GUIDEZ
Contact
cguidez@chu-reims.fr
03 26 78 77 11 ext. 0033

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion